RECRUITING

Testimonials and Navigation in Rheumatology

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The overall goal of this study is to determine whether a novel, multi-modal, patient-directed behavioral intervention initiated in rheumatology clinics is an effective approach to improve uptake of updated COVID-19 vaccine.

Official Title

Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groups with Rheumatic Diseases

Quick Facts

Study Start:2024-12-18
Study Completion:2027-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06469788

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adults (18+ years) with known AIRD
  2. * Black race and/or Latinx ethnicity
  3. * Individuals who have not obtained the updated COVID-19 vaccine series (self-report)
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Stephanie S Ford, Clinical Research Administration Manager, MS
CONTACT
2059347423
sledbetter@uabmc.edu

Principal Investigator

Maria I Danila, MD, MSc, MSPH
PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham

Study Locations (Sites)

University of Alabama at Birmingham
Birmingham, Alabama, 35294
United States
Brigham Women's Hospital
Boston, Massachusetts, 02115
United States
University of Massachusetts Chan Medical School
Worcester, Massachusetts, 01655
United States

Collaborators and Investigators

Sponsor: University of Alabama at Birmingham

  • Maria I Danila, MD, MSc, MSPH, PRINCIPAL_INVESTIGATOR, University of Alabama at Birmingham

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-18
Study Completion Date2027-08-31

Study Record Updates

Study Start Date2024-12-18
Study Completion Date2027-08-31

Terms related to this study

Keywords Provided by Researchers

  • COVID-19 vaccination
  • Rheumatic Diseases

Additional Relevant MeSH Terms

  • Rheumatologic Disease
  • Autoimmune Diseases